文献速递甲状腺疾病

超声引导下射频消融治疗儿童良性无功能甲状腺结节的安全性与有效性:62例患者四年以上随访的回顾性研究

Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation for Benign Nonfunctional Thyroid Nodules in Children: A Retrospective Study of 62 Patients with Over Four Years of Follow-Up.
PubMed 文献 · Thyroid · 2022-01-17

该回顾性研究评估了射频消融(RFA)治疗62例儿童70个良性无功能甲状腺结节的疗效与安全性,随访至少四年(59.1±10.5个月)。结节体积缩小率和技术有效率在术后第一年最高(分别为77.5%和91.4%),但至第四年下降(分别为55.1%和81.4%)。症状评分和美容评分均显著降低,总体并发症率为4.8%,结论认为RFA对选定儿童患者是一种良好的微创治疗方式,但可能不适用于双侧甲状腺结节。

要点

  • RFA术后第一年体积缩小率和技术有效率分别为77.5%和91.4%,第四年分别降至55.1%和81.4%。
  • 症状评分从4.0±2.1降至0.8±1.6(Z=-6.82,p<0.001),美容评分从3.3±0.7降至1.3±0.9(Z=-7.0,p<0.001)。
  • 总体并发症率为4.8%,双侧结节、低血供和低囊性成分是技术有效性的独立危险因素。

核心结论

  • RFA能有效缩小儿童良性无功能甲状腺结节的体积,在短期和长期随访中提供显著的症状缓解且安全性良好。
  • RFA对选定的儿童患者是一种良好的微创治疗方式,但可能不适用于儿童双侧甲状腺结节的治疗。

研究设计与样本

  • 回顾性研究,纳入62例儿童共70个良性无功能甲状腺结节,接受RFA治疗并随访四年以上。

主要发现

  • 随访至少四年(59.1±10.5个月,范围48-85个月)。
  • 术后第一年体积缩小率和技术有效率最高,分别为77.5%和91.4%,至第四年分别降至55.1%和81.4%。
  • 症状评分从4.0±2.1降至0.8±1.6(Z=-6.82,p<0.001),美容评分从3.3±0.7降至1.3±0.9(Z=-7.0,p<0.001)。
  • 结节再生长率为22.9%,其中56.3%的病例表现为疗效丧失;在疗效丧失的病例中,66.7%的结节体积大于初始表现。
  • 因疗效丧失接受第二次RFA治疗的患者再次出现疗效丧失。

临床怎么用

  • 作者认为RFA对选定的儿童患者是一种良好的微创治疗方式。
  • 作者认为RFA可能不适用于儿童双侧甲状腺结节的治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Image-guided radiofrequency ablation (RFA) for benign nonfunctional thyroid nodules in adults has been shown to be effective and safe, but few trials address the use of RFA in children. Therefore, this study was designed to assess the efficacy and safety of RFA application to benign nonfunctional thyroid nodules in children. Methods: A retrospective study of RFA for 70 benign nonfunctional thyroid nodules in 62 children with four-year follow-up was conducted. Volume reduction ratio (VRR), technique efficacy, regrowth rate, symptom score, and cosmetic score were calculated to evaluate the efficacy. Complications and side effects were recorded. Logistic regression analysis was performed to identify risk factors, and subgroup analyses were performed. Results: Patients were followed up for at least four years (59.1 ± 10.5 months, range 48-85 months). After RFA treatment, the VRR and technique efficacy rates were highest at the first year* (77.5% and 91.4%, respectively) but decreased by four years (55.1% and 81.4%, respectively). The symptom score decreased from 4.0 ± 2.1* to 0.8 ± 1.6 (Z = -6.82, p < 0.001), and the cosmetic score decreased from 3.3 ± 0.7 to 1.3 ± 0.9 (Z = -7.0, p < 0.001).* The nodule regrowth rate was 22.9%, of which 56.3% of cases represented loss of efficacy. In the cases of loss of efficacy, 66.7% had greater volume than their initial presentation. Patients who received a second RFA treatment due to loss of efficacy lost efficacy again. Bilateral nodules, low vascularity, and low cystic components were independent risk factors correlating with technique efficacy. Bilateral nodules correlated with low VRR, low efficacy rate, and high regrowth rate. Nodules with a higher proportion of cystic components had higher VRR. The overall complication rate was 4.8%. Conclusions: RFA was effective in reducing the volume of benign nonfunctional thyroid nodules in children, providing significant symptomatic relief with a good safety profile during short- and long-term follow-up. RFA is a good minimally invasive treatment modality for selected pediatric patients, and it may not be appropriate for the treatment of bilateral thyroid nodules in children.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Li L, Qiu X. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation for Benign Nonfunctional Thyroid Nodules in Children: A Retrospective Study of 62 Patients with Over Four Years of Follow-Up. Thyroid. 2022. PMID: 34915754. doi:10.1089/thy.2021.0454

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。